Literature DB >> 10321386

Disposition, toxicity, and intestinal absorption of cobaltous chloride in male Fischer 344 rats.

F Ayala-Fierro1, J M Firriolo, D E Carter.   

Abstract

The absorption and disposition of inorganic cobalt salts after oral administration have not been well characterized. The objectives of this study were to compare in vivo results with cobalt transport through the in vitro everted small intestine and to relate the disposition results to a biochemical indicator of cobalt toxicity. Cobalt chloride was given to male Fischer 344 rats orally at 33.3 mg Co(II)/kg or intravenously at 4.16 mg Co(II)/kg. By 36 h, 74.5% of the oral dose was eliminated in the feces. The liver, kidney, and heart accumulated cobalt to the greatest extent. Following the single oral dose, the blood cobalt concentration-time curve was triphasic, peaked at 3.2 h, and had an absorptive half-life of 0.9 h, an elimination phase half-life of 3.9 h, and a terminal elimination half-life of 22.9 h. Following intravenous administration, 10.1% of the dose was excreted in the feces, indicating that cobalt can be secreted in the bile. Following a single intravenous injection, the concentration-time curve displayed three segments. The first segment, which occurred during the first 4 h, had a rapid half-life of 1.3 h. The second phase, from 4 to 12 h, demonstrated a slower clearance rate with a half-life of 4.3 h. The final and slowest phase, from 12 to 36 h, had a half-life of 19 h. Intestinal jejunal ring experiments indicated that cobalt transport has both active and passive components; however, cobalt transport through the in vitro rat everted duodenum indicated that cobalt transport had almost exclusively passive components with facilitated diffusion. The finding that uptake was saturable may explain the small extent of absorption following oral dosing. Heme oxygenase studies following subcutaneous and intravenous administration resulted in an increase in activity (twofold) over controls, while oral administration did not. We concluded that the extent of cobalt absorption across the gastrointestinal tract is incomplete, and that the concentration administered and the route of exposure may determine its systemic toxicity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10321386     DOI: 10.1080/00984109909350178

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  3 in total

1.  Cobalt chloride administration in athletes: a new perspective in blood doping?

Authors:  G Lippi; M Franchini; G C Guidi
Journal:  Br J Sports Med       Date:  2005-11       Impact factor: 13.800

2.  Blood doping by cobalt. Should we measure cobalt in athletes?

Authors:  Giuseppe Lippi; Massimo Franchini; Gian Cesare Guidi
Journal:  J Occup Med Toxicol       Date:  2006-07-24       Impact factor: 2.646

3.  Effects of 3 Weeks of Oral Low-Dose Cobalt on Hemoglobin Mass and Aerobic Performance.

Authors:  Torben Hoffmeister; Dirk Schwenke; Oliver Krug; Nadine Wachsmuth; Hans Geyer; Mario Thevis; William C Byrnes; Walter F J Schmidt
Journal:  Front Physiol       Date:  2018-09-19       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.